Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maxigesic IV Bunionectomy Study- A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group and Placebo-Controlled Study

NCT02689063 is registered in ClinicalTrials.gov with AFT Pharmaceuticals, Ltd. as lead sponsor.

NCT NCT02689063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02689063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maxigesic IV Bunionectomy Study- A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group and Placebo-Controlled Study
Lead sponsor
AFT Pharmaceuticals, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
October 26, 2016
Completion date
September 15, 2017
Enrollment
276 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

post operative pain